Rubraca Rucaparib 300mg Tablets

300mg Tablet, Bottle

4.5 (154)

100,000

Rubraca 300mg Tablet is used to treat ovarian and prostate cancers. It works by blocking proteins that repair damaged DNA in cancer cells, preventing them from healing and causing them to die off, which stops their further growth. In ovarian cancer, it helps kill cancer cells and curb tumor formation, while in prostate cancer, it slows cancer growth and eases urinary difficulty, making urination easier.

Description

Introduction Of Rubraca 300mg Tablet:

Rubraca 300mg Tablet is used in the treatment of prostate and ovarian cancers. It works by stopping the form of damaged cancer cells, which stops their farther growth, and kills the damaged cancer cells.

Uses Of Rubraca 300mg Tablet:

  • Treatment of Ovarian cancer
  • Treatment of Prostate cancer

Benefits Of Rubraca 300mg Tablet:

1. In Treatment of Ovarian cancer

Ovarian cancer is a cancer that begins in the womanish organs that produce eggs (ovaries). This type of cancer is generally detected veritably late and can be fatal too. It generally spreads to the pelvis and stomach. Rubraca Tablet kills the cancer cells and also prevents the form of damaged cancer cells. It’s an effective drug but has some side goods that may be bothersome. Consult your croaker to know about the ways that can help you avoid these side goods.

2. In Treatment of Prostate cancer

Prostate gland is a small walnut- sized gland that produces seminal fluid, which nourishes and transports sperm in males. The most common symptom of prostate cancer is difficulty with urination, but occasionally there are no symptoms at all. Rubraca Tablet decreases or stops the growth of cancer cells and also relieves difficulty in passing urine. This makes it easier to urinate.

Medium Of Action Rubraca 300mg Tablet:

Rubraca 300mg Tablet prevents (by blocking certain proteins) cancer cells from repairing their damaged DNA, causing them to die.

Contact Us

Info Table
Packaging Type Bottle
Packaging Size Tablet
Brand Name Rubraca
Manufacturer Clovis Oncology
Brand Rubraca
Manufactured By Clovis Oncology
Composition Rucaparib
Shelf Life 24 to 36 Month
Vendor Info
Benefits
Reviews

Description

Introduction Of Rubraca 300mg Tablet:

Rubraca 300mg Tablet is used in the treatment of prostate and ovarian cancers. It works by stopping the form of damaged cancer cells, which stops their farther growth, and kills the damaged cancer cells.

Uses Of Rubraca 300mg Tablet:

  • Treatment of Ovarian cancer
  • Treatment of Prostate cancer

Benefits Of Rubraca 300mg Tablet:

1. In Treatment of Ovarian cancer

Ovarian cancer is a cancer that begins in the womanish organs that produce eggs (ovaries). This type of cancer is generally detected veritably late and can be fatal too. It generally spreads to the pelvis and stomach. Rubraca Tablet kills the cancer cells and also prevents the form of damaged cancer cells. It’s an effective drug but has some side goods that may be bothersome. Consult your croaker to know about the ways that can help you avoid these side goods.

2. In Treatment of Prostate cancer

Prostate gland is a small walnut- sized gland that produces seminal fluid, which nourishes and transports sperm in males. The most common symptom of prostate cancer is difficulty with urination, but occasionally there are no symptoms at all. Rubraca Tablet decreases or stops the growth of cancer cells and also relieves difficulty in passing urine. This makes it easier to urinate.

Medium Of Action Rubraca 300mg Tablet:

Rubraca 300mg Tablet prevents (by blocking certain proteins) cancer cells from repairing their damaged DNA, causing them to die.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Rubraca Rucaparib 300mg Tablets”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Rubraca 300mg Tablet used for?
Rubraca 300mg Tablet (Rucaparib) is used to treat ovarian cancer and prostate cancer.
It works by blocking proteins that repair damaged DNA in cancer cells, preventing them from healing and causing them to die off, which stops their further growth.
It kills cancer cells and prevents the formation of damaged cancer cells that could otherwise spread to the pelvis and stomach, curbing tumor formation.
It slows or stops the growth of cancer cells and also relieves difficulty in passing urine, a common symptom of prostate cancer, making urination easier.
Rubraca Tablet is manufactured by Clovis Oncology and contains Rucaparib 300mg, supplied as a bottle with a shelf life of 24 to 36 months.
For detailed clinical and safety information, refer to MedlinePlus Drug Information, a trusted external medical resource.

Related products